169 related articles for article (PubMed ID: 25799154)
21. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
22. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
[TBL] [Abstract][Full Text] [Related]
23. Complement C4d-specific antibodies for the diagnosis of lung cancer.
Ajona D; Okrój M; Pajares MJ; Agorreta J; Lozano MD; Zulueta JJ; Verri C; Roz L; Sozzi G; Pastorino U; Massion PP; Montuenga LM; Blom AM; Pio R
Oncotarget; 2018 Jan; 9(5):6346-6355. PubMed ID: 29464077
[TBL] [Abstract][Full Text] [Related]
24. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
25. [Study of mast cell, eosinophil and fibroblast activation in bronchoalveolar lavage fluid in patients with lung cancer].
Márquez Pérez FL; Blasco Ferrándiz R; Callol Sánchez L; Chivato Pérez T; Villegas Fernández F; Gómez de Terreros Sánchez FJ
Arch Bronconeumol; 1998 Nov; 34(10):484-8. PubMed ID: 9881213
[TBL] [Abstract][Full Text] [Related]
26. Complement activation in astrocytomas: deposition of C4d and patient outcome.
Mäkelä K; Helén P; Haapasalo H; Paavonen T
BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer.
de Castro J; Rodríguez MC; Martínez-Zorzano VS; Sánchez-Rodríguez P; Sánchez-Yagüe J
Am J Clin Pathol; 2014 Jul; 142(1):111-20. PubMed ID: 24926094
[TBL] [Abstract][Full Text] [Related]
29. [Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer].
Załteska J; Pirozyński M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1996; 64(1-2):11-8. PubMed ID: 8630459
[TBL] [Abstract][Full Text] [Related]
30. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
31. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
32. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
33. A correlative study of bronchial cytology, bronchoalveolar lavage (BAL) and serum tumor markers in the diagnosis of lung carcinoma.
Nikliński J; Chyczewski L; Chyczewska E; Laudański J; Furman M
Folia Histochem Cytobiol; 1993; 31(4):211-3. PubMed ID: 8138002
[TBL] [Abstract][Full Text] [Related]
34. [The diagnostic value of flow cytometric DNA analysis of bronchial washing and lavage fluids in lung cancer].
Tao M; Li J; Wu J
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Aug; 19(4):222-5. PubMed ID: 9596829
[TBL] [Abstract][Full Text] [Related]
35. A panel of sputum-based genomic marker for early detection of lung cancer.
Jiang F; Todd NW; Li R; Zhang H; Fang H; Stass SA
Cancer Prev Res (Phila); 2010 Dec; 3(12):1571-8. PubMed ID: 20864512
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
Ma WL
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical staining for stratifin and OCIAD2 in bronchial washing specimens increases sensitivity for diagnosis of lung cancer.
Itoguchi N; Nakagawa T; Murata Y; Li D; Shiba-Ishii A; Minami Y; Noguchi M
Cytopathology; 2015 Dec; 26(6):354-61. PubMed ID: 25376185
[TBL] [Abstract][Full Text] [Related]
38. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Dikmen E; Kara M; Dikmen G; Cakmak H; Dogan P
Eur J Cardiothorac Surg; 2003 Feb; 23(2):194-9; discussion 199-20. PubMed ID: 12559342
[TBL] [Abstract][Full Text] [Related]
39. Cytological diagnosis of lung cancer in Chiang Mai, Thailand: cyto-histological correlation and comparison of sensitivity of various methods.
Rangdaeng S; Ya-In C; Settakorn J; Chaiwun B; Bhothirat C; Sirivanichai C; Aramratana A
J Med Assoc Thai; 2002 Sep; 85(9):953-61. PubMed ID: 12450072
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Utility of C4d by Direct Immunofluorescence in Bullous Pemphigoid.
Damman J; Edwards G; van Doorn MB; Horvath B; Diercks GFH
Am J Dermatopathol; 2021 Oct; 43(10):727-729. PubMed ID: 33395046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
